Hydroxyurea therapy in chronic myelogenous leukemia
نویسندگان
چکیده
منابع مشابه
Cyclic leukocyte oscillations in chronic myelogenous leukemia during hydroxyurea therapy.
By B. J. KENNEDY T HE SUCCESSFUL TREATMENT of cancer and leukemia by agents which have hematosuppressive effects depends upon a selective toxicity, whereby the tumor cell is inhibited rather than the normal cell. Further information is needed on the life of the leukocyte, particularly the generative cycle and the normal or abnormal physiologic rhythms. The basic mechanism of the movement of leu...
متن کاملimatinib therapy in chronic myelogenous leukemia and thyroid function tests.
introduction: imatinib, a tyrosine kinase inhibitor which resulted in much improvement in the treatment of chronic myelogenous leukemia (cml), may adversely affect thyroid gland function. to date, assessment of thyroid function during imatinib therapy has limited to retrospective studies. the aim of this study was to evaluate the effects of imatinib on thyroid function in a prospective manner. ...
متن کاملRandomized Comparison of Busulfan and Hydroxyurea in Chronic Myelogenous Leukemia: Prolongation of Survival by Hydroxyurea
By R. Hehlmann, H. Heimpel, J. Hasford, H.J. Kolb, H. Pralle, D.K. Hossfeld, W. QueiBer, H. Lbffler, B. Heinze, A. Georgii, P.v. Wussow, C. Bartram, M. GrieBhammer, L. Bergmann, U. Essers, C. Falge, A. Hochhaus, U. QueiBer, C. Sick, P. Meyer, N. Schmitz, K. Verpoort, H. Eimermacher, F. Walther, M. Westerhausen, U.R. Kleeberg, A. Heilein, A. Kabisch. C. Barz, R. Zimmermann, G. Meuret, A. Tichell...
متن کاملImatinib Therapy in Chronic Myelogenous Leukemia
Chronic myelogenous leukemia (CML) is a clonal proliferative disease originating from a pluripotential stem cell in which a 9:22 translocation, Philadelphia (Ph) chromosome, results in the production of BCR-ABL fusion protein that has constitutive tyrosine kinase activity and deregulates signal transduction pathways, thus causing leukemia. The natural course of CML is usually triphasic (chronic...
متن کاملFlow Cytometry in Chronic Myelogenous Leukemia Blast Crisis
Background: Chronic myelogenous leukemia (CML) is a myeloproliferative disorder due to BCR-ABL1 translocation. Patients showing transformation into blast crisis (BC) have poorer treatment response and prognosis. Methods: A retrospective study was conducted in the department of Pathology, Maulana Azad Medical College, New Delhi, India, over a time period of 5 years (2014-2019) to evaluate the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1972
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(197204)29:4<1052::aid-cncr2820290454>3.0.co;2-7